Table 2 Predictors of mortality in CTD-PAH on univariate analysis

Male sex

3.42 (1.27 to 9.22)

0.02

Age at PAH diagnosis, years

1.01 (0.98 to 1.04)

0.72

Underlying CTD (SSc)

1.27 (0.44 to 3.66)

0.66

WHO FC at baseline

3.64 (1.32 to 10.01)

0.01

Baseline 6MWD*

0.70 (0.52 to 0.95)

0.02

Pericardial effusion

2.83 (1.12 to 7.12)

0.03

mPAP at baseline, mmHg

1.01 (0.98 to 1.05)

0.42

mRAP at baseline, mmHg

1.11 (1.02 to 1.19)

0.01

Warfarin therapy

0.26 (0.11 to 0.66)

0.004

Combination therapy

0.38 (0.16 to 0.92)

0.03